{"database": "openregs", "table": "documents", "rows": [["FDA-2003-N-0196-0088", "FDA", "FDA-2003-N-0196", "Reference 28 - International Conference on Harmonization (ICH) Guidance for Industry - S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals SIC(R2) (Revision 1), September 2008 re Over-the-Counter Sunscreen Drug Products\u2014Regulatory Status of Enzacamene", "Supporting & Related Material", "Background Material", "2015-02-25T05:00:00Z", 2015, 2, null, null, "2015-02-25T18:19:59Z", null, 0, 0, "0900006481a1138e"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2003-N-0196-0088"], "units": {}, "query_ms": 0.5060320254415274, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}